NM_002834.5:c.1713-146G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002834.5(PTPN11):c.1713-146G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0619 in 664,276 control chromosomes in the GnomAD database, including 8,595 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.056 ( 1313 hom., cov: 33)
Exomes 𝑓: 0.063 ( 7282 hom. )
Consequence
PTPN11
NM_002834.5 intron
NM_002834.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.698
Publications
9 publications found
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]
PTPN11 Gene-Disease associations (from GenCC):
- LEOPARD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- metachondromatosisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-112504549-G-A is Benign according to our data. Variant chr12-112504549-G-A is described in ClinVar as Benign. ClinVar VariationId is 1293594.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PTPN11 | NM_002834.5 | c.1713-146G>A | intron_variant | Intron 14 of 15 | ENST00000351677.7 | NP_002825.3 | ||
| PTPN11 | NM_001330437.2 | c.1725-146G>A | intron_variant | Intron 14 of 15 | NP_001317366.1 | |||
| PTPN11 | NM_001374625.1 | c.1710-146G>A | intron_variant | Intron 14 of 15 | NP_001361554.1 | |||
| PTPN11 | XM_011538613.3 | c.1722-146G>A | intron_variant | Intron 14 of 15 | XP_011536915.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0565 AC: 8593AN: 152132Hom.: 1318 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8593
AN:
152132
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0634 AC: 32488AN: 512026Hom.: 7282 AF XY: 0.0620 AC XY: 17033AN XY: 274666 show subpopulations
GnomAD4 exome
AF:
AC:
32488
AN:
512026
Hom.:
AF XY:
AC XY:
17033
AN XY:
274666
show subpopulations
African (AFR)
AF:
AC:
716
AN:
13582
American (AMR)
AF:
AC:
5137
AN:
26386
Ashkenazi Jewish (ASJ)
AF:
AC:
84
AN:
16822
East Asian (EAS)
AF:
AC:
19585
AN:
30456
South Asian (SAS)
AF:
AC:
4230
AN:
53980
European-Finnish (FIN)
AF:
AC:
148
AN:
44178
Middle Eastern (MID)
AF:
AC:
65
AN:
2164
European-Non Finnish (NFE)
AF:
AC:
1019
AN:
296788
Other (OTH)
AF:
AC:
1504
AN:
27670
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
862
1724
2587
3449
4311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0565 AC: 8598AN: 152250Hom.: 1313 Cov.: 33 AF XY: 0.0630 AC XY: 4688AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
8598
AN:
152250
Hom.:
Cov.:
33
AF XY:
AC XY:
4688
AN XY:
74438
show subpopulations
African (AFR)
AF:
AC:
2340
AN:
41550
American (AMR)
AF:
AC:
2201
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
19
AN:
3472
East Asian (EAS)
AF:
AC:
3179
AN:
5172
South Asian (SAS)
AF:
AC:
468
AN:
4818
European-Finnish (FIN)
AF:
AC:
23
AN:
10622
Middle Eastern (MID)
AF:
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
AC:
219
AN:
68016
Other (OTH)
AF:
AC:
134
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
302
604
906
1208
1510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
848
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.